Dusa Pharmaceuticals, Inc. (DUSA) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	28.74M
Marketable securities	3.57M
Accounts receivable, net of allowance for doubtful accounts of $58,000 and $60,000 in 2011 and 2010, respectively	2.77M
Inventory	3.78M
Prepaid and other current assets
TOTAL CURRENT ASSETS	39.76M
Restricted cash	176.15K
Property, plant and equipment, net	1.65M
Deferred charges and other assets	64.86K
TOTAL ASSETS	41.66M
Accounts payable	1.29M
Accrued compensation	1.32M
Other accrued expenses	2.93M
Deferred revenue
TOTAL CURRENT LIABILITIES	5.69M
Deferred revenue	893.23K
Warrant liability	4.53M
Other liabilities	137.47K
TOTAL LIABILITIES	11.25M
COMMITMENTS AND CONTINGENCIES (NOTE 13)
Capital Stock Authorized: 100,000,000 shares; 40,000,000 shares designated as common stock, no par, and 60,000,000 shares issuable in series or classes; and 40,000 junior Series A preferred shares. Issued and outstanding: 24,649,364 and 24,239,365 shares of common shares, no par, at June 30, 2011 and December 31, 2010, respectively	151.85M
Additional paid-in capital	12.46M
Accumulated deficit	-133.91M
Accumulated other comprehensive income	5.52K
TOTAL SHAREHOLDERS' EQUITY	30.41M
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	41.66M

Entities mentioned with DUSA

View All Entities